AB1570-HPR RATE OF THERAPEUTIC FAILURES PRESENTED AFTER SWITCHING FROM TOCILIZUMAB TO ANOTHER BIOLOGICALS IN PATIENTS WITH RHEUMATOID ARTHRITIS FACING A SITUATION OF SUPPLY SHORTAGE | Publicación